Changes of serum VEGF and hs-CRP levels in coronary heart disease
10.3969/j.issn.1005-1678.2016.12.051
- VernacularTitle:冠心病患者血清中血管内皮细胞生长因子与超敏C反应蛋白变化
- Author:
Zheng DONG
;
Liming SUN
;
Yilian WANG
;
Haitao XU
;
Luoqing WANG
- Keywords:
coronary heart disease;
vascular endothelial growth factor;
high-sensitivity C-reactive protein;
prediction
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(12):177-179
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the changes of vascular endothelial growth factor (VEGF) and high-sensitivity C-reactive protein (hs-CRP) levels in the patients with coronary heart disease (CHD), and its clinical significance.Methods Nighty cases with CHD in our hospital from January 2015 to February 2016 were selected as study group, while 30 cases healthy persons underwent physical examination were selected as control group, and the study group were divided into stable angina pectoris ( SAP) group, acute myocardial infarction ( AMI) group and unstable angina pectoris ( UAP) group.The serum VEGF and hs-CRP levels were detected by ELISA.Results The serum VEGF and hs-CRP levels in study group were higher than those in control group (P<0.05).The serum VEGF and hs-CRP levels in AMI group were higher than those in SAP group and UAP group, the serum VEGF and hs-CRP levels in UAP group were higher than SAP group (P<0.05).There was positive correlation between serum level of VEGF and hs-CRP(r=0.626,P<0.05).The ROC showed a higher diagnostic value of VEGF and hs-CRP on CHD.Conclusion The serum levels of VEGF and hs-CRP has a higher diagnostic value and accuracy on CHD, which could evaluate the patient’s condition and predict the progress of cardiovascular events.
